SCHEMBL6795031

SCHEMBL6795031

CC(=O)c1ccc(-c2ccccc2C(=O)Nc2ccnc(CCN(C(=O)OC(C)(C)C)c3ccccc3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMO Q99835 2/20 0.40
ALDH1A1 P00352 2/20 0.39
GAA P10253 2/20 0.38
KDM4E B2RXH2 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
F2 P00734 2/20 0.38
SYK P43405 1/20 0.36
AURKB Q96GD4 1/20 0.36
INCENP Q9NQS7 1/20 0.36
OPRL1 P41146 1/20 0.36
MCHR1 Q99705 1/20 0.36
HTT P42858 2/20 0.36
LMNA P02545 1/20 0.36
MTTP P55157 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA4 P43681 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6796397 0.90 SMO (0.41) SMOALDH1A1GAAKDM4EL3MBTL1
SCHEMBL6788717 0.89 MAPT (0.44) SMOALDH1A1GAASYKAURKB
SCHEMBL6795028 0.85 BACE1 (0.41) SMOALDH1A1GAAKDM4EL3MBTL1
SCHEMBL6796112 0.84 MEN1 (0.41) F2
SCHEMBL6794786 0.83 POLB (0.38) ALDH1A1GAAL3MBTL1OPRL1MTTP
SCHEMBL6792911 0.82 SMO (0.47) SMOALDH1A1GAAKDM4EL3MBTL1
SCHEMBL6795007 0.82 SMO (0.48) SMOALDH1A1GAAKDM4EL3MBTL1
SCHEMBL6645327 0.82 ALDH1A1 (0.43) ALDH1A1GAAKDM4EF2HTT
SCHEMBL6794007 0.82 L3MBTL1 (0.44) SMOALDH1A1GAAKDM4EL3MBTL1
SCHEMBL6793636 0.82 SMO (0.42) SMOALDH1A1GAAKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 SMO 2094/4885ALDH1A1 1427/4885GAA 977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.